Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Purple Biotech Ltd. Director's Dealing 2020

Jul 7, 2020

7004_rns_2020-07-07_56bd987e-d0e8-4a79-b3a0-67111f8b40cc.htm

Director's Dealing

Open in viewer

Opens in your device viewer

_________ false

����� ����� ��"� 2 381
KITOV PHARMA LTD
Corporation no: 520031238 12724
- - -
Israel Securities Authority Tel Aviv Stock Exchange C003 ( Public ) Reported via MAGNA: 07/07/2020
www.isa.gov.il www.tase.co.il Reference: 2020-02-064261 Time of broadcast: 08:48 08:44:04

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Statement of acquisition of beneficial ownership by individuals

d8567021_sc13-g_isa.pdf

����� ������ �"�/�.����-13G-Armistice Capital, LLC
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 23/06/2020
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: [email protected]   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: Masas Ludmer Adi Position of Signatory in the reporting corporation: Company Controller Name of Employer Company:
Address: Menachem Begin Drive 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1
Israel